Teiko- Publications

25-Marker Spectral Flow Panel for Immune Profiling in Fixed Whole Blood

Magee & Lancaster et al. CYTO (2025)

Unsupervised clustering reveals cell types in 40 specimen aGVHD PBMC cytometry dataset

Leavitt & Black et al. CYTO (2025)

Is Fresh Really That Fresh? Time-Dependent Quality Loss in Live Specimens.

Lancaster & Magee et al. IO360 (2025)

Unsupervised clustering reveals cell types in 145 specimen melanoma PBMC cytometry dataset

Leavitt & Black et al. SITC Spring Scientific (2025)

It’s on-site: Eliminating site-to-site variability with whole blood collection kits using 30+ marker TokuProfile mass cytometry assay

Sigal & Cheng et al. SITC (2024)

It’s about time: Rapid on-site fixation of whole blood samples prior to high-dimensional flow cytometric analysis

Magee & Sigal et al. SITC (2024)

Whitepaper: 25-Marker Spectral Flow Panel for Immune Profiling in Fixed Whole Blood

Magee & Lancaster et al. Teiko (2025)

Is Fresh Really That Fresh? Time-Dependent Quality Loss in Live Specimens.

Lancaster & Magee et al. AACR IO (2025)

Rapid on-site fixation of whole blood samples for high-dimensional spectral flow cytometric analysis

Magee & Sigal et al. ICCS (2024)

Assessment of Batch Normalization Methods on Mass Cytometry Data

Chronister, Leavitt, & Black, et al. ICCS (2024)

Systemic dysfunction and plasticity of the immune macroenvironment in cancer models

Allen & Hiam et al. Nature Medicine. (2020)

Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma

Kovacsovics-Bankowski & Sweere. JITC (2024)

Mass cytometry immune profiling to detect signatures of clinical activity of bintrafusp alfa in patients with advanced non-small cell lung cancer

McAdams & Medina et al. ASCO (2023)

Peripheral immune features associated with severe adverse events in melanoma

Healy & Kovacsovics-Bankowski et al. SITC (2022)

Immune features associated with clinical benefit and adverse events in response to immunotherapy in UC patients

Healy & Sweere et al. Cancer Res (2023)

Peripheral immune features associated with severe immune-related adverse events and clinical benefit in checkpoint inhibitor-treated melanoma

Kovacsovics-Bankowski & Sweere. SMR (2023)

Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients

Burnett, Okholm, & Tenvooren, et al. Immunity (2022)

Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response

Levine & Hiam-Galvez et al. Immunity. (2021)

Comprehensive immune monitoring of clinical trials to advance human immunotherapy

Hartmann et al. Cell Rep (2019)

Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes

Rahim, Okholm, & Jones et al. Cell (2023)

Systemic immunity Is required for effective cancer immunotherapy

Spitzer, Carmi, & Reticker-Flynn et al. Cell (2017)

Publications by Teiko and friends.

Read original work on cytometry methods, specimen collection, and biomarker discovery and validation.

25-Marker Spectral Flow Panel for Immune Profiling in Fixed Whole Blood

Unsupervised clustering reveals cell types in 40 specimen aGVHD PBMC cytometry dataset

Is Fresh Really That Fresh? Time-Dependent Quality Loss in Live Specimens.

Unsupervised clustering reveals cell types in 145 specimen melanoma PBMC cytometry dataset

It’s on-site: Eliminating site-to-site variability with whole blood collection kits using 30+ marker TokuProfile mass cytometry assay

It’s about time: Rapid on-site fixation of whole blood samples prior to high-dimensional flow cytometric analysis

Whitepaper: 25-Marker Spectral Flow Panel for Immune Profiling in Fixed Whole Blood

Is Fresh Really That Fresh? Time-Dependent Quality Loss in Live Specimens.

Rapid on-site fixation of whole blood samples for high-dimensional spectral flow cytometric analysis

Assessment of Batch Normalization Methods on Mass Cytometry Data

Systemic dysfunction and plasticity of the immune macroenvironment in cancer models

Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma

Mass cytometry immune profiling to detect signatures of clinical activity of bintrafusp alfa in patients with advanced non-small cell lung cancer

Peripheral immune features associated with severe adverse events in melanoma

Immune features associated with clinical benefit and adverse events in response to immunotherapy in UC patients

Peripheral immune features associated with severe immune-related adverse events and clinical benefit in checkpoint inhibitor-treated melanoma

Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients

Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response

Comprehensive immune monitoring of clinical trials to advance human immunotherapy

Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes

Systemic immunity Is required for effective cancer immunotherapy

Teiko